RIPK1 and Alzheimer disease: The most important observation in this study was that NEC-1, an inhibitor of RIPK1, prevented hepatic and renal cell death in a BDL model of ACLF induced by injection of LPS, providing the first proof of the importance of this pathway in the pathogenesis of ACLF from AD.